Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160717 · ClinicalTrials.gov registry record
Risk of Diabetes in Young Turner Syndrome Patients
A clinical trial of Turner Syndrome, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT02160717: Completed study of Turner Syndrome, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02160717 is a study of Turner Syndrome that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 120 participants, below the 511-participant average among 14 other Turner Syndrome trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02160717, a study of Turner Syndrome, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Turner Syndrome is a common genetic disorder. Seventy percent of adults with Turner Syndrome have abnormalities in glucose metabolism which can lead to diabetes. The current screening guidelines for diabetes in Turner Syndrome are not specific and involve a fasting blood sugar once a year. The objective of this study is to determine if there are abnormalities in glucose metabolism and pancreatic function in young girls with Turner Syndrome. The study hypothesis is that pancreatic dysfunction (specifically of the beta cells that make insulin) is more prevalent in girls with Turner Syndrome compared to healthy controls.
Primary Outcome
Disposition index will be calculated based on the results of the oral glucose tolerance test using minimal modeling (computer program)
Conditions Studied
Study Locations (1)
Ohio
- Children's Hospital Medical Center, Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-06 |
What the finished NCT02160717 record still lists
NCT02160717 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 511-participant average among 14 other Turner Syndrome trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Turner Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02160717 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02160717 about?
NCT02160717 is a clinical study titled "Risk of Diabetes in Young Turner Syndrome Patients". Turner Syndrome is a common genetic disorder. Seventy percent of adults with Turner Syndrome have abnormalities in glucose metabolism which can lead to diabetes. The current screening guidelines for diabetes in Turner Syndrome are not specific and involve a fasting blood sugar once a year. The objec...
What is the current status of trial NCT02160717?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-05. Estimated completion is 2017-06.
What conditions does trial NCT02160717 study?
This clinical trial studies the following conditions: Turner Syndrome.
Who is sponsoring clinical trial NCT02160717?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02160717 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Turner Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02160717's enrollment target sits among peer trials
120 7th of 14 higher than 8 of 14 other Turner Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Turner Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Natural History of Noncirrhotic Portal Hypertension
RECRUITING
-
UTHealth Turner Syndrome Research Registry
RECRUITING
-
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
RECRUITING · Phase 4
-
Vosoritide for Short Stature in Turner Syndrome
RECRUITING · Phase 2
-
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
RECRUITING
-
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia